• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-10

  The reference study develops a nonviral lipid nanoparticle platform for intravesical delivery of chemically modified p21 mRNA, addressing both tumor-suppressor loss and the delivery barriers associated with systemic mRNA therapy. In bladder cancer models, localized p21 restoration inhibited tumor growth, altered cell-cycle and DNA-damage signaling, and limited systemic exposure, while also highlighting important translational questions about formulation, dosing, and model-to-human transfer.

• Rapamycin, Lipophagy, and Lipotoxicity in Salmon Cells

  2026-08-09

  Phadwal and colleagues show that rapamycin-induced autophagy promotes lipid-droplet turnover and reduces lipotoxic features in Atlantic salmon SHK-1 cells. By combining lipidomics, proteomics, and cellular evidence, the study identifies altered unsaturated triacylglycerol storage and possible autophagic targeting of lipid-regulatory proteins, providing a useful framework for fish lipid-metabolism research.

• Protoporphyrin IX Workflows for Heme and Ferroptosis

  2026-08-08

  Protoporphyrin IX connects heme formation, iron handling, and photodynamic assay design, while its unusual solubility profile demands disciplined formulation and light controls. This guide translates the METTL16–SENP3–LTF ferroptosis findings into practical, clearly bounded experiments for hepatocellular carcinoma research.

• SM-102: From LNP Mechanism to Translational Strategy

  2026-08-07

  SM-102 is more than an LNP raw material: it is a formulation variable that links endosomal biology, tissue-specific delivery, and translational execution. This article examines how SM-102 can inform mRNA vaccine development and localized therapeutic mRNA programs, using recent bladder cancer evidence to define opportunities, boundaries, and practical next steps.

• FPH1 (BRD-6125): Redefining Hepatocyte Expansion in Modern A

  2026-08-07

  Discover how FPH1 (BRD-6125) advances hepatocyte proliferation and functional maturation in cell-based assays. This article provides deep technical insights and unique protocol guidance for primary human hepatocyte culture.

• Tin Mesoporphyrin IX (chloride): Precision Heme Oxygenase In

  2026-08-06

  Tin Mesoporphyrin IX (chloride) is a nanomolar, competitive heme oxygenase inhibitor validated in metabolic and antiviral research. APExBIO’s C5606 enables reproducible control of heme catabolism, with rigorous benchmarks for in vitro and in vivo studies.

• 3D Organoid–CAF Models Reveal Stroma-Driven PDAC Chemoresist

  2026-08-06

  Schuth et al. present a patient-specific 3D co-culture system combining pancreatic tumor organoids and matched cancer-associated fibroblasts, enabling precise investigation of stromal contributions to chemoresistance in PDAC. Their findings highlight the necessity of stromal elements for physiologically relevant drug screening and implicate CAF-induced EMT as a key mechanism.

• Dissecting Proliferation and Death in In Vitro Cancer Drug T

  2026-08-05

  Schwartz’s dissertation establishes a refined framework for evaluating drug responses in cancer cell models by distinguishing between proliferative arrest and cell death. This distinction enables more precise mechanistic interpretation and better informs preclinical drug assessment strategies.

• Tin Mesoporphyrin IX: Advancing Heme Oxygenase Inhibition As

  2026-08-05

  Tin Mesoporphyrin IX (chloride) offers unmatched specificity and reproducibility for dissecting heme oxygenase pathways in metabolic and virology research. Its nanomolar potency and proven in vivo performance set a new standard for targeted modulation of heme catabolism.

• Afatinib (SKU A4746): Reliable EGFR/HER2 Inhibition in Cance

  2026-08-04

  This authoritative guide addresses key laboratory challenges in cell viability, proliferation, and cytotoxicity assays using Afatinib (SKU A4746). Supported by recent assembloid model evidence, it provides scenario-driven insights for selecting, optimizing, and interpreting results with this irreversible ErbB family tyrosine kinase inhibitor. Bench scientists gain practical value for experimental reproducibility and translational research.

• L-Phenylephrine: Selective α1A Adrenergic Agonist for Resear

  2026-08-04

  L-Phenylephrine is a selective adrenergic α1A receptor agonist widely used in cardiovascular and neurobiological research. Its high receptor specificity, ability to modulate gene expression, and reproducible physiological effects make it a benchmark tool for dissecting α1-adrenergic signaling pathways.

• (S)-(+)-Ibuprofen: Precision COX Inhibitor for Inflammation

  2026-08-03

  (S)-(+)-Ibuprofen (APExBIO, B1018) delivers robust, selective COX inhibition for high-fidelity inflammation and pain mechanism research. Explore protocol-ready guidance, troubleshooting insights, and practical workflow enhancements for both in vitro and in vivo applications.

• SLC2A5-Driven Fructose Metabolism in CNS Lymphoma: Single-Ce

  2026-08-03

  This study leverages single-cell multi-omics to reveal that SLC2A5-mediated fructose metabolism is a metabolic vulnerability in primary CNS lymphoma, shaped by hypoxia and low glucose in the tumor microenvironment. These findings offer new avenues for targeted therapy and provide a blueprint for dissecting tumor–microenvironment interactions in rare brain lymphomas.

• MLKL-Driven Lysosomal Permeabilization Orchestrates Necropto

  2026-08-02

  This study elucidates how MLKL polymerization at lysosomal membranes initiates membrane permeabilization, releasing cathepsins—especially cathepsin B—to execute necroptosis. These findings define a pivotal mechanistic link between lysosomal integrity and regulated necrotic cell death, offering new targets for intervention in inflammatory and degenerative diseases.

• Ordered DNA Frameworks Advance Enzymatic Oligonucleotide Syn

  2026-08-01

  A recent study introduces highly ordered tetrahedral DNA nanostructures (TDN) to improve the efficiency and fidelity of enzymatic oligonucleotide synthesis. This innovation significantly enhances enzyme accessibility and substrate affinity, enabling high-yield, low-error DNA synthesis, with important implications for DNA information storage and synthetic biology.

7997 records 10/534 page Previous Next First page 上5页 678910 下5页 Last page